ARIAD Pharmaceuticals, Inc. V. Eli Lilly & Co.: Brief of Amici Curiae Mark D. Janis and Timothy R. Holbrook in Support of Neither Party

34 Pages Posted: 4 Nov 2009

See all articles by Mark D. Janis

Mark D. Janis

Indiana University Maurer School of Law

Timothy R. Holbrook

Emory University

Date Written: October 14, 2009

Abstract

Professors Mark D. Janis (Indiana University School of Law-Bloomington) and Timothy R. Holbrook (Emory University School of Law) argue that there is no written description requirement in 35 U.S.C. § 112, ¶ 1 separate from requiring the patent specification contain a disclosure sufficient to enable one of skill in the art to make and use the claimed invention. Neither the statutory language itself does nor the policies articulated by the Federal Circuit support a separate written description requirement. Enablement doctrine alone is sufficient both to correlate claim scope with the inventor's contribution and to determine whether the disclosure provides adequate support for later-added claims. Janis and Holbrook further urge the Federal Circuit not to use the § 132 "new matter" prohibition to craft a "back-door" written description requirement.

Keywords: patent, disclosure, enablement, written description, ariad, federal circuit

JEL Classification: O34

Suggested Citation

Janis, Mark David and Holbrook, Timothy Richard, ARIAD Pharmaceuticals, Inc. V. Eli Lilly & Co.: Brief of Amici Curiae Mark D. Janis and Timothy R. Holbrook in Support of Neither Party (October 14, 2009). Emory Public Law Research Paper No. 09-81; Emory Law and Economics Research Paper No. 09-52. Available at SSRN: https://ssrn.com/abstract=1499200 or http://dx.doi.org/10.2139/ssrn.1499200

Mark David Janis

Indiana University Maurer School of Law ( email )

211 S. Indiana Avenue
Bloomington, IN 47405
United States

Timothy Richard Holbrook (Contact Author)

Emory University ( email )

1301 Clifton Road
Atlanta, GA 30322
United States
404-712-0353 (Phone)

Register to save articles to
your library

Register

Paper statistics

Downloads
61
rank
345,877
Abstract Views
793
PlumX Metrics